Thermo Fisher Scientific, Inc and Merck KGaA are the leading players in the research antibodies and reagent market
The research antibodies and reagents market are projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7% during the forecast period. Factors such as due to research reproducibility growing demand for high-quality antibodies, increasing research in proteomics and genomics, and increasing R&D activity in the life sciences industry, are driving the global research antibodies and reagents market and market is expected to witness significant growth in the coming years.
The research antibodies and reagents market players are focusing on various organic and inorganic growth strategies, such as product launches, acquisition, collaboration, partnerships, agreements, and expansion to increase their market foothold. The prominent market players are Thermo Fisher Scientific (US), Merck KGaA (Germany), Abcam plc (UK), Becton, Dickinson, and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US). However, market is highly competitive, with many leading market players based across developed regions such as the US and Europe.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific Inc. is one of the leading companies in research antibodies and reagent market. Thermo fisher operates in four basic business segments, namely, Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Services. Through life sciences solutions, the company operates in research antibodies and reagent market. The company provides reagents, instruments, and consumables used in biological and medical research, discovery, the production of new drugs and vaccines, and the diagnosis of diseases through its Life Sciences Solutions segment. The company operates in more than 180 countries across North America, Europe, Asia, the Middle East, Africa, and Latin America. Some of its major subsidiaries are ABgene Limited (UK), Athena Diagnostics, Inc. (US), Thermo Fisher Scientific C.V. (Netherlands), Life Technologies Corporation (US), Prionics AG (Switzerland), Thermo Detection de Mexico, S.A. de C.V., Fisher Scientific Japan, Ltd., and Fisher Scientific (SEA) Pte. Ltd. (Singapore).
Merck KGaA is a leading science and technology company with a strong global presence in more than 120 countries. The company operates from life science segment in research antibodies and reagents. Merck has a strong product and technology portfolio for research antibodies and offers innovative solutions for the life science industry. The company has a wide costumer base which supports company’s portfolio of life science products. The company majorly focuses on geographical expansions to increase its costomer base.
Related Reports:
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) - Global forecast to 2027
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
